The treatment, approved in January, is the first generic of Advair to hit the market. It will be priced between $93.71 and $153.14.
The FDA didn’t approve Advair generics from Novartis and Hikma Pharmaceuticals.
More articles on pharmacy:
Better pharmacy access sought for rural Colorado residents
Following its rival, Sanofi and Regeneron slash price of cholesterol drug by 60%
Mount Carmel’s chief pharmacy officer out amid overprescribing scandal
Register to Attend Webinar
Presenters:
Frank Stevens, Strata|Josh Wiggins, Strata
Next Up in Pharmacy
-
New customs requirements taking effect Oct. 22 could disrupt access for millions of Americans who buy prescription drugs from Canadian…
-
The American Hospital Association is urging Congress to permanently bar rebate models in the 340B program. AHA issued the request…
-
Eli Lilly received FDA approval Sept. 24 for Onswik, a once-weekly basal insulin injection for adults with Type 2 diabetes.…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
